Tollenaar RAEM - Search Results

1

Two truncating variants in FANCC and breast cancer risk.

Dörk T, Peterlongo P, Mannermaa A, Bolla MK, Wang Q, Dennis J, Ahearn T, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Augustinsson A, Freeman LEB, Beckmann MW, Beeghly-Fadiel A, Behrens S, Bermisheva M, Blomqvist C, Bogdanova NV, Bojesen SE, Brauch H, Brenner H, Burwinkel B, Canzian F, Chan TL, Chang-Claude J, Chanock SJ, Choi JY, Christiansen H, Clarke CL, Couch FJ, Czene K, Daly MB, Dos-Santos-Silva I, Dwek M, Eccles DM, Ekici AB, Eriksson M, Evans DG, Fasching PA, Figueroa J, Flyger H, Fritschi L, Gabrielson M, Gago-Dominguez M, Gao C, Gapstur SM, García-Closas M, García-Sáenz JA, Gaudet MM, Giles GG, Goldberg MS, Goldgar DE, Guénel P, Haeberle L, Haiman CA, Håkansson N, Hall P, Hamann U, Hartman M, Hauke J, Hein A, Hillemanns P, Hogervorst FBL, Hooning MJ, Hopper JL, Howell T, Huo D, Ito H, Iwasaki M, Jakubowska A, Janni W, John EM, Jung A, Kaaks R, Kang D, Kapoor PM, Khusnutdinova E, Kim SW, Kitahara CM, Koutros S, Kraft P, Kristensen VN, Kwong A, Lambrechts D, Marchand LL, Li J, Lindström S, Linet M, Lo WY, Long J, Lophatananon A, Lubiński J, Manoochehri M, Manoukian S, Margolin S, Martinez E, Matsuo K, Mavroudis D, Meindl A, Menon U, Milne RL, Mohd Taib NA, Muir K, Mul… See abstract for full author list ➔ Dörk T, et al. Among authors: tollenaar raem. Sci Rep. 2019 Aug 29;9(1):12524. doi: 10.1038/s41598-019-48804-y. Sci Rep. 2019. PMID: 31467304 Free PMC article.

2

Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients.

Papelard H, de Bock GH, van Eijk R, Vliet Vlieland TP, Cornelisse CJ, Devilee P, Tollenaar RA. Papelard H, et al. Br J Cancer. 2000 Sep;83(6):719-24. doi: 10.1054/bjoc.2000.1331. Br J Cancer. 2000. PMID: 10952774 Free PMC article.

3

[From gene to disease; from BRCA1 or BRCA2 to breast cancer].

Devilee P, Tollenaar RA, Cornelisse CJ. Devilee P, et al. Ned Tijdschr Geneeskd. 2000 Dec 30;144(53):2549-51. Ned Tijdschr Geneeskd. 2000. PMID: 11191790 Review. Dutch.

4

Clinical and pathological features of BRCA1 associated carcinomas in a hospital-based sample of Dutch breast cancer patients.

de Bock GH, Tollenaar RA, Papelard H, Cornelisse CJ, Devilee P, van de Vijver MJ. de Bock GH, et al. Br J Cancer. 2001 Nov 2;85(9):1347-50. doi: 10.1054/bjoc.2001.2103. Br J Cancer. 2001. PMID: 11720473 Free PMC article.

5

Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

de Bock GH, Tollenaar RA, Papelard H, Vliet Vlieland TP, Devilee P, Cornelisse CJ, Vandenbroucke JP. de Bock GH, et al. J Natl Cancer Inst. 2003 Jul 2;95(13):1011-2; author reply 1012-3. doi: 10.1093/jnci/95.13.1011. J Natl Cancer Inst. 2003. PMID: 12837842 No abstract available.

6

Possible consequences of applying guidelines to healthy women with a family history of breast cancer.

van Asperen CJ, Tollenaar RA, Krol-Warmerdam EM, Blom J, Hoogendoorn WE, Seynaeve CM, Brekelmans CT, Devilee P, Cornelisse CJ, Klijn JG, de Bock GH. van Asperen CJ, et al. Eur J Hum Genet. 2003 Aug;11(8):633-6. doi: 10.1038/sj.ejhg.5201021. Eur J Hum Genet. 2003. PMID: 12891386

7

[Genetic research with stored human tissue: a coding procedure with optimal use of information and protection of privacy].

Schmidt MK, van Leeuwen FE, Klaren HM, Tollenaar RA, van 't Veer LJ. Schmidt MK, et al. Ned Tijdschr Geneeskd. 2004 Mar 20;148(12):564-8. Ned Tijdschr Geneeskd. 2004. PMID: 15074178 Review. Dutch.

8

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers.

van Sprundel TC, Schmidt MK, Rookus MA, Brohet R, van Asperen CJ, Rutgers EJ, Van't Veer LJ, Tollenaar RA. van Sprundel TC, et al. Br J Cancer. 2005 Aug 8;93(3):287-92. doi: 10.1038/sj.bjc.6602703. Br J Cancer. 2005. PMID: 16052221 Free PMC article.

9

Association between the CHEK2*1100delC germ line mutation and estrogen receptor status.

de Bock GH, Mourits MJ, Schutte M, Krol-Warmerdam EM, Seynaeve C, Blom J, Brekelmans CT, Meijers-Heijboer H, van Asperen CJ, Cornelisse CJ, Devilee P, Tollenaar RA, Klijn JG. de Bock GH, et al. Int J Gynecol Cancer. 2006;16 Suppl 2:552-5. doi: 10.1111/j.1525-1438.2006.00694.x. Int J Gynecol Cancer. 2006. PMID: 17010071

10

Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation.

Schmidt MK, Tollenaar RA, de Kemp SR, Broeks A, Cornelisse CJ, Smit VT, Peterse JL, van Leeuwen FE, Van't Veer LJ. Schmidt MK, et al. J Clin Oncol. 2007 Jan 1;25(1):64-9. doi: 10.1200/JCO.2006.06.3024. Epub 2006 Nov 28. J Clin Oncol. 2007. PMID: 17132695

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

467 results

Search Page

Filters